EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PD-L1 Negative Advanced Non-Small Cell Lung Cancer: Practice Patterns and Real-World Outcomes

Audrey-Ann Bégin iD, Maude Dubé-Pelletier, Catherine Labbé iD, Vicky Mai, Michaël Maranda-Robitaille, Marie-Hélène Denault

Current Oncology · 28.02.2026 · 33 (3) · 144

DOI: 10.3390/curroncol33030144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 28.02.2026. Verfasst von Audrey-Ann Bégin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Université Laval, 2725 Ch Ste-Foy, Quebec, QC G…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, B7-H1 Antigen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The standard first-line treatment for metastatic non-small cell lung cancer (NSCLC) without oncogenic alterations and programmed death-ligand 1 (PD-L1) expression < 1% is a combination of chemotherapy (CT) and immunotherapy (IO). However, real-world overall survival (OS) appears more modest than in clinical trials, averaging 10–13 months. This retrospective study aimed to assess treatment patterns and real-world outcomes at the Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ). Patients diagnosed between January 2019 and December 2023 with advanced PD-L1

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsB7-H1 AntigenHumansRetrospective StudiesFemaleMaleAgedMiddle AgedImmunotherapy

Stichwörter der Autor:innen

PD-L1 negativechemo-immunotherapyimmune checkpoint inhibitorsmetastatic non-small cell lung cancerreal-world evidence

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Université Laval, 2725 Ch Ste-Foy, Quebec, QC G1V 4G5, Canada.

ORCID-Profile: Audrey-Ann Bégin, Catherine Labbé

Zitieren

APA

Bégin, A. A., Dubé-Pelletier, M., Labbé, C., Mai, V., Maranda-Robitaille, M., & Denault, M. H. (2026). PD-L1 Negative Advanced Non-Small Cell Lung Cancer: Practice Patterns and Real-World Outcomes. Current Oncology, 33(3), 144. https://doi.org/10.3390/curroncol33030144

Vancouver

Bégin AA, Dubé-Pelletier M, Labbé C, Mai V, Maranda-Robitaille M, Denault MH. PD-L1 Negative Advanced Non-Small Cell Lung Cancer: Practice Patterns and Real-World Outcomes. Current Oncology. 2026;33(3):144. doi:10.3390/curroncol33030144

BibTeX
@article{Bgin2026,
  author = {Bégin, Audrey-Ann and Dubé-Pelletier, Maude and Labbé, Catherine and Mai, Vicky and Maranda-Robitaille, Michaël and Denault, Marie-Hélène},
  title = {PD-L1 Negative Advanced Non-Small Cell Lung Cancer: Practice Patterns and Real-World Outcomes},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {144},
  doi = {10.3390/curroncol33030144}
}
Kostenlos starten →